73 related articles for article (PubMed ID: 18624259)
21. Oral contraceptive use and BRCA penetrance: a case-only study.
Pasanisi P; Hédelin G; Berrino J; Chang-Claude J; Hermann S; Steel M; Haites N; Hart J; Peled R; Gafà L; Leggio L; Traina A; Amodio R; Primic-Zakelj M; Zadnik V; Veidebaum T; Tekkel M; Berrino F
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2107-13. PubMed ID: 19549808
[TBL] [Abstract][Full Text] [Related]
22. BRCA1/2 predictive testing: a study of uptake in two centres.
Brooks L; Lennard F; Shenton A; Lalloo F; Ambus I; Ardern-Jones A; Belk R; Kerr B; Craufurd D; Eeles R; Gareth Evans D
Eur J Hum Genet; 2004 Aug; 12(8):654-62. PubMed ID: 15138457
[TBL] [Abstract][Full Text] [Related]
23. Genetic issues in patients with breast cancer.
Fossland VS; Stroop JB; Schwartz RC; Kurtzman SH
Surg Oncol Clin N Am; 2009 Jan; 18(1):53-71, viii. PubMed ID: 19056042
[TBL] [Abstract][Full Text] [Related]
24. Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.
Evans DG; Lalloo F; Ashcroft L; Shenton A; Clancy T; Baildam AD; Brain A; Hopwood P; Howell A
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2318-24. PubMed ID: 19661091
[TBL] [Abstract][Full Text] [Related]
25. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations.
Khoury-Shakour S; Lejbkowicz F; Barnett-Griness O; Tamir A; Pinchev M; Rennert G
Eur J Cancer Prev; 2009 Sep; 18(5):361-7. PubMed ID: 19543094
[TBL] [Abstract][Full Text] [Related]
26. Molecular and in silico analysis of BRCA1 and BRCA2 variants.
Tommasi S; Pilato B; Pinto R; Monaco A; Bruno M; Campana M; Digennaro M; Schittulli F; Lacalamita R; Paradiso A
Mutat Res; 2008 Sep; 644(1-2):64-70. PubMed ID: 18694767
[TBL] [Abstract][Full Text] [Related]
27. Quality of life in asymptomatic BRCA1/2 mutation carriers.
Dagan E; Shochat T
Prev Med; 2009 Feb; 48(2):193-6. PubMed ID: 19084553
[TBL] [Abstract][Full Text] [Related]
28. Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancer.
Beetstra S; Suthers G; Dhillon V; Salisbury C; Turner J; Altree M; McKinnon R; Fenech M
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2565-71. PubMed ID: 18842997
[TBL] [Abstract][Full Text] [Related]
29. Establishing a family risk assessment clinic for breast cancer.
Mulsow J; Lee J; Dempsey C; Rothwell J; Geraghty JG
Breast J; 2009; 15 Suppl 1():S33-8. PubMed ID: 19775328
[TBL] [Abstract][Full Text] [Related]
30. The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases.
De Vecchi G; Verderio P; Pizzamiglio S; Manoukian S; Bernard L; Pensotti V; Volorio S; Ravagnani F; Radice P; Peterlongo P
Cancer Detect Prev; 2008; 32(2):140-3. PubMed ID: 18640791
[TBL] [Abstract][Full Text] [Related]
31. Subjective interpretation of inconclusive BRCA1/2 cancer genetic test results and transmission of information to the relatives.
Cypowyj C; Eisinger F; Huiart L; Sobol H; Morin M; Julian-Reynier C
Psychooncology; 2009 Feb; 18(2):209-15. PubMed ID: 19061202
[TBL] [Abstract][Full Text] [Related]
32. Advantages of the high resolution melting in the detection of BRCA1 or BRCA2 mutation carriers.
Jiménez Ide J; Esteban Cardeñosa E; Palanca Suela S; González EB; Bolufer Gilabert P;
Clin Biochem; 2009 Oct; 42(15):1572-6. PubMed ID: 19616529
[TBL] [Abstract][Full Text] [Related]
33. Prevention of beta-thalassemia in a large Pakistani family through cascade testing.
Baig SM; Din MA; Hassan H; Azhar A; Baig JM; Aslam M; Anjum I; Farooq M; Hussain MS; Rasool M; Nawaz S; Qureshi JA; Zaman T
Community Genet; 2008; 11(1):68-70. PubMed ID: 18196920
[TBL] [Abstract][Full Text] [Related]
34. Towards more effective and equitable genetic testing for BRCA1 and BRCA2 mutation carriers.
Hopper JL; Dowty JG; Apicella C; Southey MC; Giles GG; Winship I
J Med Genet; 2008 Jul; 45(7):409-10. PubMed ID: 18456714
[No Abstract] [Full Text] [Related]
35. Carrier testing in haemophilia A and B: adult carriers' and their partners' experiences and their views on the testing of young females.
Dunn NF; Miller R; Griffioen A; Lee CA
Haemophilia; 2008 May; 14(3):584-92. PubMed ID: 18282148
[TBL] [Abstract][Full Text] [Related]
36. Genetic counselling in unexpected familial recurrence of achondroplasia.
Dodinval P; Le Marec B
Am J Med Genet; 1987 Dec; 28(4):949-54. PubMed ID: 3688033
[TBL] [Abstract][Full Text] [Related]
37. New evidence of genetic factors influencing sexual orientation in men: female fecundity increase in the maternal line.
Iemmola F; Camperio Ciani A
Arch Sex Behav; 2009 Jun; 38(3):393-9. PubMed ID: 18561014
[TBL] [Abstract][Full Text] [Related]
38. Environment and genetics: Making sense of the noise.
Petherick A
Nature; 2012 May; 485(7400):S64-5. PubMed ID: 22648504
[No Abstract] [Full Text] [Related]
39. A theoretical psychological perspective on predictive testing for late onset hereditary diseases.
Mularczyk E; Decruyenaere M; Denayer L; Evers-Kiebooms G
Genet Couns; 2007; 18(4):367-78. PubMed ID: 18286817
[TBL] [Abstract][Full Text] [Related]
40. Gene tests for some, not all. Genetic testing helps some people glimpse their cardiovascular future.
Harv Heart Lett; 2008 Jan; 18(5):1-2. PubMed ID: 18293528
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
